Researchers from Baltimore-based Johns Hopkins Medicine led the study, according to a Feb. 26 news release from the health system.
The study authors are suggesting that oral prednisone, frequently used to treat heart inflammation, be used sparingly in patients with lupus to lower the risk of pericarditis recurrence.
Read the full study here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
